Background: Seasonality in insulin sensitivity has been the focus of controversial literature in the past decades. The aim of this study was to analyze seasonality of insulin use in patients with diabetes who were followed in German general practices.

Methods: This study included patients affected by type 1 (T1DM) or type 2 diabetes mellitus (T2DM) who received intensified conventional insulin therapy over a period of at least 12 months between 2013 and 2015. The main outcome was the median insulin dose per day (calculated daily insulin doses, CDDs) between June and August (summer) and between December and February (winter).

Results: The present study included 1197 T1DM patients and 3836 T2DM patients from 492 general practitioner or diabetologist practices. The mean age was 45.4 years (SD = 16.2 years) in the T1DM group and 65.2 years (SD = 14.1 years) in the T2DM group. The most frequent basal insulin therapy was insulin glargine (T1DM: 45.7%; T2DM: 41.1%), and the most frequent bolus insulin therapy was insulin lispro in the T1DM group (38.7%) and human insulin in the T2DM group (45.2%). The consumption of basal and bolus insulins did not significantly differ between summer and winter in T1DM individuals (basal therapy: 30.8 international units (IU)/day versus 31.2 IU/day; bolus therapy: 39.4 IU/day versus 37.8 IU/day). This consumption was also similar between the two seasons in the T2DM group (basal therapy: 31.0 IU/day versus 30.6 IU/day; bolus therapy: 44.3 IU/day versus 44.1 IU/day).

Conclusions: There was no significant difference in the use of basal and bolus insulin therapies between summer and winter in German patients with T1DM or T2DM.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5950994PMC
http://dx.doi.org/10.1177/1932296817703994DOI Listing

Publication Analysis

Top Keywords

iu/day versus
16
seasonality insulin
12
insulin therapy
12
t2dm group
12
insulin
11
study included
8
t1dm group
8
therapy insulin
8
bolus insulin
8
basal bolus
8

Similar Publications

Introduction: Previous randomised controlled trials (RCTs) have indicated a protective role of pregnancy supplementation with fish oil and high-dose vitamin D, respectively, on offspring asthma, infections and several other disorders in early childhood. However, current evidence is not considered sufficient for recommending these supplements in pregnancy. In two RCTs, we aim to investigate whether these protective effects can be confirmed in larger trials with the goal of changing clinical practice and improving child health.

View Article and Find Full Text PDF

Promising initial studies on vitamin D (VD) supplementation as an adjunct treatment for major depressive disorder (MDD) require rigorously designed randomized controlled trials (RCTs). We aim to investigate the effects of augmenting standard MDD treatment with VD supplementation and examine factors influencing the treatment outcome. This article describes the study design, measures, and baseline characteristics.

View Article and Find Full Text PDF
Article Synopsis
  • This study explores how the daily dose of follicle-stimulating hormone (FSH) impacts the chances of suboptimal ovarian response during IVF, specifically using POSEIDON's criteria.
  • It examines a group of 4005 women with normal hormone levels undergoing their first IVF/ICSI cycle, assessing whether varying FSH doses (≤300 IU vs >300 IU) influence the retrieval of 4-9 oocytes.
  • Results show that increasing the FSH dose did not decrease the risk of suboptimal response, while factors like female age, and hormone levels were found to be significant predictors instead.
View Article and Find Full Text PDF
Article Synopsis
  • Vitamin D is important for immune health and might affect the risk of graft-versus-host disease (GvHD) in patients receiving hematopoietic stem cell transplants (HSCT).
  • A review of studies found that HSCT patients often have low vitamin D levels (around 12.8 to 29.2 ng/mL) and that various supplementation methods exist, but results on vitamin D's impact on GvHD risk are mixed.
  • While some studies link low vitamin D to a higher risk of acute GvHD, a clearer connection was found with chronic GvHD, indicating that further research is needed to assess vitamin D's potential therapeutic benefits in HSCT patients.
View Article and Find Full Text PDF

: Polycystic ovarian syndrome (PCOS) is a widespread endocrine disorder affecting 5-18% of females in their childbearing age. The aim of this study is to assess the efficacy of combining a low dosage of human chorionic gonadotropin (HCG) along with clomiphene citrate (CC) for stimulating ovulation in infertile women diagnosed with CC-resistant PCOS. : A randomized controlled trial was carried out on 300 infertile CC-resistant PCOS women.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!